tiprankstipranks
Trending News
More News >
EQL Pharma AB (DE:7JK)
FRANKFURT:7JK
Germany Market

EQL Pharma AB (7JK) Income Statement

Compare
0 Followers

EQL Pharma AB Income Statement

Last quarter (Q1 2023), EQL Pharma AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q1, EQL Pharma AB's net income was $7.39M. See EQL Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 22Mar 21Mar 20Mar 19Dec 16
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 95.73M$ 68.83M$ 36.82M$ 27.66M$ 19.72M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ 17.27M$ 4.13M$ 4.80M$ 1.56M
EBITDA
$ 38.84M$ 28.72M$ 7.29M$ 3.37M$ 5.11M
Operating Income
$ 38.56M$ 11.44M$ 3.15M$ -1.42M$ 3.55M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ 31.55M$ 10.38M$ 2.71M$ -1.51M$ 3.54M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

EQL Pharma AB Earnings and Revenue History